{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:23:53Z","timestamp":1791278633849,"version":"4.1.0"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T00:00:00Z","timestamp":1442880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138841","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T14:08:22Z","timestamp":1442930902000},"page":"e0138841","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":81,"title":["Prevalence of Enhanced Granular Expression of Thrombospondin Type-1 Domain-Containing 7A in the Glomeruli of Japanese Patients with Idiopathic Membranous Nephropathy"],"prefix":"10.1371","volume":"10","author":[{"given":"Takamasa","family":"Iwakura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naro","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1681\/ASN.2005010028","article-title":"Management of membranous nephropathy: when and what for treatment","volume":"16","author":"D Cattran","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2009121220","article-title":"Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy","volume":"21","author":"P Ronco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"LH Beck Jr","year":"2009","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2215\/CJN.07210810","article-title":"Anti-phospholipase A\u2082 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy","volume":"6","author":"JM Hofstra","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1681\/ASN.2010090967","article-title":"Anti-phospholipase A2 receptor antibody in membranous nephropathy","volume":"22","author":"W Qin","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/ndt\/gfr247","article-title":"An immunofluorescence test for phospholipase-A\u2082-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis","volume":"26","author":"E Hoxha","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2012030242","article-title":"Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy","volume":"23","author":"JM Hofstra","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"E Hoxha","year":"2012","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e62151","DOI":"10.1371\/journal.pone.0062151","article-title":"Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy","volume":"8","author":"YJ Oh","year":"2013","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/ndt\/gfs439","article-title":"Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy","volume":"28","author":"B Svobodova","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"ref11","article-title":"Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy","author":"S Akiyama","journal-title":"Clin Exp Nephrol"},{"key":"ref12","first-page":"353","article-title":"Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy","volume":"34","author":"A Segarra-Medrano","year":"2014","journal-title":"Nefrologia"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ki.2012.486","article-title":"Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy","volume":"83","author":"D Kanigicherla","year":"2013","journal-title":"Kidney Int"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMc1011678","article-title":"PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy","volume":"364","author":"H Debiec","year":"2011","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.1038\/srep08803","article-title":"Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis","volume":"5","author":"H Dai","year":"2015","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"NM Tomas","year":"2014","journal-title":"N Engl J Med"},{"key":"ref17","first-page":"57","article-title":"Distribution of IgG subclasses in membranous nephropathy","volume":"58","author":"T Doi","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0090-1229(88)90181-X","article-title":"Glomerular and serum immunoglobin G subclasses in membranous nephropathy and antiglomerular basement membrane nephritis","volume":"46","author":"LH No\u00ebl","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/ki.1997.32","article-title":"IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis","volume":"51","author":"H Imai","year":"1997","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfg616","article-title":"Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy","volume":"19","author":"H Ohtani","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"E Hoxha","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/modpathol.2012.237","article-title":"IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression","volume":"26","author":"CC Huang","year":"2013","journal-title":"Mod Pathol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:29:39Z","timestamp":1589009379000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138841"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Remuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,22]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138841","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,22]]}}}